NCT00616187 - Atorvastatin in Relapsing-Remitting Multiple Sclerosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

June 30, 2007

Conditions

Relapsing Remitting Multiple Sclerosis

Interventions

DRUG

interferon beta treatment to add-on atorvastatin treatment

IFN-β-1a 22 µg s.c. 3 times weekly or IFN-β-1b s.c. every other day (3 months baseline) and add on oral daily 80 mg atorvastatin (9 months add on treatment)

DRUG

untreated to atorvastatin treatment

no treatment(3 months baseline)and oral daily 80 mg atorvastatin (9 months add on treatment)